| Literature DB >> 36118147 |
Tsuyoshi Hara1, Eisuke Kogure2, Yuta Sugita3, Takeshi Ohnuma2, Akira Kubo1.
Abstract
Objectives: Home-visit rehabilitation is critical for cancer patients because it facilitates recovery. However, few studies have reported relevant information and practices concerning this patient support. This study investigated the factors influencing the self-efficacy of cancer survivors receiving home-visit rehabilitation compared with non-cancer home-visit rehabilitation users by matching propensity scores.Entities:
Keywords: activities of daily living; home medical care; life-space mobility; muscle strength
Year: 2022 PMID: 36118147 PMCID: PMC9411037 DOI: 10.2490/prm.20220042
Source DB: PubMed Journal: Prog Rehabil Med ISSN: 2432-1354
Fig. 1.Flow chart showing inclusion and exclusion of study participants.
Demographics and clinical characteristics of participating home-visit rehabilitation users (n=30)
| Cancer survivors | Home-visit rehabilitation | ||
| n=15 | n=15 | P value | |
| Age (years) | 77.6±11.1 | 74.7±11.7 | 0.367 |
| Sex | |||
| Female | 6 | 7 | 1.000 |
| Male | 9 | 8 | |
| Comorbidities | |||
| Cerebrovascular diseases | 6 | 4 | 0.700 |
| Orthopedic diseases | 8 | 9 | 1.000 |
| Cardiac diseases | 5 | 5 | 1.000 |
| Respiratory diseases | 2 | 1 | 1.000 |
| Intractable diseases | 2 | 3 | 1.000 |
| Period during which home-visit rehabilitation was received (months) | 34.9±50.1 | 39.1±37.8 | 0.345 |
| Frequency of home-visit rehabilitation (times/week) | 1.3±0.5 | 1.4±0.6 | 0.486 |
| Frequency of daycare facility for adults (times/week) | 0.6±0.9 | 0.8±0.9 | 0.512 |
| Presence of caregiver | |||
| Spouse | 9 | 5 | 0.272 |
| Child | 4 | 7 | 0.450 |
| Parents | 1 | 0 | 1.000 |
| Brother | 0 | 1 | 1.000 |
| Niece | 0 | 1 | 1.000 |
| Others | 1 | 1 | 1.000 |
| Cancer diagnosis a | |||
| Thyroid cancer | 1 | - | |
| Breast cancer | 1 | - | |
| Lung cancer | 2 | - | |
| Gastric cancer | 3 | - | |
| Colon cancer | 1 | - | |
| Bladder cancer | 2 | - | |
| Prostate cancer | 1 | - | |
| Uterine cancer | 2 | - | |
| Ovarian cancer | 1 | - | |
| Leukemia | 3 | - | |
| Duration since cancer diagnosis (months) | 84.5±99.2 | - | |
| Cancer treatment a | |||
| Surgery | 11 | - | |
| Chemotherapy | 7 | - | |
| Others | 1 | - | |
| Primary disease of home-visit rehabilitation users without cancer | |||
| Cerebral hemorrhage | - | 1 | |
| Subarachnoid hemorrhage | - | 1 | |
| Symptomatic epilepsy | - | 1 | |
| Parkinson’s disease | - | 1 | |
| Charcot–Marie–Tooth disease | - | 1 | |
| Dementia with Lewy bodies | - | 1 | |
| Lumbar spinal canal stenosis | - | 2 | |
| Ossification of posterior longitudinal ligament | - | 1 | |
| Spinal cord herniation | - | 1 | |
| Knee osteoarthritis | - | 1 | |
| Calcaneal fracture | - | 1 | |
| Osteonecrosis of the femoral head | - | 1 | |
| Pyogenic arthritis of knee | - | 1 | |
| Chronic kidney disease | - | 1 |
Data given as number or mean ± standard deviation.
a Includes duplicate cases.
Self-efficacy and other measurements of participating home-visit rehabilitation users
| Cancer survivors | Home-visit rehabilitation users without cancer | P value | ||
| Self-efficacy | SEADL (points) | 14.2±5.8 | 14.5±4.7 | 0.624 |
| SEGE (points) | 9.9±5.3 | 7.9±4.9 | 0.486 | |
| Other measurements | GS (kg) | 19.7±10.0 | 21.1±5.9 | 0.345 |
| CS-30 (repetitions) | 6.4±6.1 | 4.5±5.9 | 0.389 | |
| FIM (points) | 104.6±21.0 | 107.2±13.1 | 0.935 | |
| mFIM (points) | 74.2±15.8 | 74.2±11.2 | 0.683 | |
| cFIM (points) | 30.4±6.4 | 33.0±4.8 | 0.045* | |
| LSA (points) | 24.0±10.2 | 28.2±9.7 | 0.250 |
Data given as mean ± standard deviation.
* Significant difference by Mann–Whitney U test.
Correlation between self-efficacy and other measurements for each group
| Cancer survivors | Home-visit rehabilitation users without cancer | |||
| SEADL | SEGE | SEADL | SEGE | |
| GS | 0.731* | 0.478 | −0.116 | −0.354 |
| CS-30 | 0.787* | 0.679* | 0.483 | 0.037 |
| FIM | 0.735* | 0.383 | 0.645* | 0.273 |
| mFIM | 0.772* | 0.447 | 0.758* | 0.388 |
| cFIM | 0.316 | 0.036 | 0.245 | −0.171 |
| LSA | 0.582* | 0.403 | 0.309 | 0.066 |
* Significant correlation for Spearman’s rank correlation coefficient.
Fig. 2.Correlation plots of self-efficacy for activities of daily living of cancer survivors (left) and home-visit rehabilitation users without cancer (right) with grip strength (top), 30-second chair stand test (middle), and Life-Space Assessment (bottom). Asterisks indicate significant correlation for Spearman’s rank correlation coefficient.